Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use-Reference-Cited by-同舟云学术

Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use

Published:2021-05-31 Issue:6 Volume:35 Page:691-700
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Paik Julia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00830-z.pdf

Reference34 articles.

1. Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43.

2. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.

3. National Institute for Health and Care Excellence. Multiple sclerosis in adults: management. 2014. https://nice.org.uk/guidance/cg186. Accessed 10 May 2021.

4. Montalban X, Gold R, Thompson AJ, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler. 2018;24(2):96–120.

5. Rae-Grant A, Day GS, Marrie RA, et al. Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777–88.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis;Brain Research;2024-01

2. A novel stability indicating mass compatible reversed‐phase high‐performance liquid chromatography for the determination of Diroximel fumarate and its related impurities;SEPARATION SCIENCE PLUS;2023-12-07

3. A DFT study on the probability of using the heteroatom decorated graphitic carbonitride (g-C3N4) species for delivering of three novel Multiple sclerosis drugs;Journal of Molecular Graphics and Modelling;2023-12

4. The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis;Biomedicine & Pharmacotherapy;2023-03

5. S1PR1 modulators in multiple sclerosis: Efficacy, safety, comparison, and chemical structure insights;European Journal of Medicinal Chemistry;2023-03